Jeffrey is Vice President of Regulatory at Abzena, based out of the company’s Bristol, PA facility. With over 30 years of experience in drug development, Jeffrey leads product strategy, regulatory planning and quality management initiatives across early development and manufacturing. Before joining Abzena, he served as Senior VP of Regulatory Affairs at ProEd Regulatory. A microbiologist by training, Jeffrey has worked extensively in contract research organization (CRO) settings, specializing in CMC regulatory strategy, analytical method development and Phase I trial readiness.